BO`LMACHALAR FIBRILYATSIYASI BO`LGAN INTERVENTSION AMALIYOT O`TKAZILGAN BEMORLARDA ANTITROMBOTIK TERAPIYA
Creators
- 1. Toshkent tibbiyot akademiyasi, Toshkent, O`zbekiston
Description
Bo’lmachalar fibrillyatsiyasi bilan og’rigan interventsion amaliyot o’tqazgan bemorlar uchun optimal antitrombotik davolash sxemasi klinik jihatdan to’laligicha o’rganilmagan. Oral antitrombotik terapiya va 2 komponentli, shuningdek, uch komponentli antitrombotik terapiya deb nomlanuvchi davolash usullari nazariy jihatdan bo’lmachalar fibrillyatsiyasi tufayli tromboemboliya xavfini va koronar stentlar tufayli tromb rivojlanish ehtimolini kamaytirish uchun tavsiya qilinadi. Biroq, uch komponentli antitrombotik terapiya sezilarli asoratlarga va hayot uchun xavfli bo’lgan qon ketish xavfini sezilarli darajada oshiradi (2). Bu borada olib borilayotgan ilmiy izlanishlar mavjud bo'lib, ular uch komponentli antitrombotik terapiyani muqobil antitrombotik terapiya usullari bilan taqqoslaydi, bu orqali oral antitrombotik terapiya va 2 komponentli terapiyada asoratlar rivojlanish xavfini baholash mumkin.
Files
293-298 G‘aniyev B.B.pdf
Files
(969.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:afc8c6787eda34d10f48e01202879e3a
|
969.4 kB | Preview Download |
Additional details
References
- 1.Dominick J. Angiolillo ,,Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention''
- 2. Sahil Khera, ... Deepak L. Bhatt. ,,Percutaneous Coronary Intervention''
- 3. HIROSHI KOIWAYA, NOZOMI WATANABE, NEHIRO KURIYAMA AND YOSHISATO SHIBATA,, Direct Oral Anticoagulants Would Be Best Choice for Atrial Fibrillation Patients After Coronary Stenting: Retrospective Study in a Japanese Population'' Kurume Medical Journal, 68, 00-00, 2021
- 4. Michniewicz E., Mlodawska E., Lopatowska P., Tomaszuk-Kazberuk A. and Malyszko J. : "Patients with atrial fibrillation and coronary artery disease–double trouble". Adv Med Sci 2018; 63: 30.
- 5. Capodanno D., Alfonso F., Levine G.N., Valgimigli M. and Angiolillo D.J. : "Dual antiplatelet therapy: appraisal of the ACC/AHA and ESC focused updates". J Am Coll Cardiol 2018; 72: 103.
- 6. Dominick J. Angiolillo ,,Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention''
- 7. Michniewicz E., Mlodawska E., Lopatowska P., Tomaszuk-Kazberuk A. and Malyszko J. : "Patients with atrial fibrillation and coronary artery disease–double trouble". Adv Med Sci 2018; 63: 30.
- 8. Capodanno D., Alfonso F., Levine G.N., Valgimigli M. and Angiolillo D.J. : "Dual antiplatelet therapy: appraisal of the ACC/AHA and ESC focused updates". J Am Coll Cardiol 2018; 72: 103.
- 9. Renad M Altoukhi1, Reema A Alshouimi1, Shahad M Al Rammah1, Mohammed Y Alzahrani2, Abdulaali R Almutairi3, Abdulmajeed M Alshehri2, Osamah M Alfayez4, Majed S Al Yami2, Omar A Almohamme ,,Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis.'' Cardiovascular medicine http://orcid.org/0000-0002-3792-4106
- 10. ТУРСУНОВА, Л., & ЖАББАРОВ, О. (2023). ПРИМЕНЕНИЯ САКУБИТРИЛ/ВАЛСАРТАНА У БОЛЬНЫХ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ С НИЗКОЙ ФРАКЦИЕЙ ВЫБРОСА.